Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC⁺ CD4⁺ cell levels: a surrogate marker candidate of HIV-induced intestinal damage.

The animals showed a trend for sDPP4 increase at the end of the IL‐21 treatment (week 6 p.i) and a statistically significant increase at the following time point that was four weeks after IL‐21 administration (week 10 p.i, p < 0.01).

also in 53,322 other papers